期刊文献+

红花注射液治疗老年性高血压的临床研究 被引量:3

Clinical study of safflower injection in treatment of senile hypertension
下载PDF
导出
摘要 目的观察红花注射液治疗老年性高血压病的临床疗效。方法100例老年性高血压病人随机分为两组,治疗组50例,常规西药治疗加红花注射液;对照组50例,常规西药治疗,观察两组用药前后的临床疗效、血液流变学情况及动脉硬化改善情况。结果治疗组显效率为70.0%(35/50),总有效率96.0%(48/50);对照组显效率48.0%(24/50),总有效率为78.0%(39/50),差异显著(P<0.05);治疗组血压下降明显优于对照组;症状积分、踝臂指数(ABI)、心踝指数(CAVI)值、血液流变学改善方面治疗组明显优于对照组(P<0.05)。结论红花注射液能有效地治疗老年性高血压。 Objective To observe the clinical efficacy of safflower injection in treatment of senile hypertension. Methods 100 elderly patients with hypertension were randomly divided into two groups, including treatment group (50 cases) treated with conventional western medicine and safflower injection and control group (50 cases) treated with conventional western medicine. The clinical efficacy of drugs before and after treatment, hemorheology situation and arteriosclerosis were observed. Results The efficiency rate of treatment group was 70.00% (35/50) and total effective rate with 96.00 (48/50)%, whereas the efficiency rate of the control group was 48.00% (24/50), the total effective rate was 78. 00% (39/50). The treatment group blood pressure significantly decreased, compared with the control group. The symptom score, ankle-brachial index (ABI), heart ankle index (CAVI) value and hemorrheology were more obvious improvement in treatment group than that in control group (P〈0.05). Conclusion Safflower injection is effective for se- nile hypertension.
出处 《西部医学》 2010年第1期27-28,31,共3页 Medical Journal of West China
关键词 红花注射液 高血压 踝臂指数 心踝指数 Safflower injection Hypertension Ankle-brachial index Heart ankle index
  • 相关文献

参考文献5

二级参考文献21

共引文献306

同被引文献25

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2汪洋.红花注射液对高血压病患者氧自由基及红细胞流变性的影响[J].西北药学杂志,2006,21(3). 被引量:7
  • 3李颖.红花注射液治疗原发性高血压的临床研究[J].湖南中医学院学报,2006,26(4):42-43. 被引量:15
  • 4Dahlof B,Sever PS,Poulter NR,et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm(ASCOT-BPLA):a multicentre randomised controlled trial[J].Lancet,2005,366(9489):895-906. 被引量:1
  • 5Barzilay JI,Davis BR,Cutler JA,et al.Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment:a report from the Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)[J].Arch Intern Med,2006,166(20):2191-2201. 被引量:1
  • 6Jadad AR, Moore RA, Carroll D, et al.Assessing the quality of reports of randomized clinical trials : Is blinding necessary? [ J ]. Controlled Clin trials, 1996,17 ( 1 ): 1-12. 被引量:1
  • 7Xu T, Ju Z, Tong W, et al. Relationship of C-reactive protein with hypertension and interactions between increased C-reactive protein and other risk faction on hypertension in Mongolian people [ J ]. Circ J, 2009,72 ( 8 ) : 1324-1328. 被引量:1
  • 8Tsioufis C, Thomopoulos K, DimitriadiskK. The incremental effect of obstructive sleep apnea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects [ J ]. J Hypertens, 2008,25 (1) :141-146. 被引量:1
  • 9Kitahara Y, Hattori N, Yokoyama A, et al. Effect of SAAS on braehial-ankle pulse wave velocity in patients with open-labeled study [ J. Respir Med,2008,100( 1 ) :2160-2169. 被引量:1
  • 10Czarina A, Celajado M, Calhoun DA. Treatment of resistant hypertension [ J ]. Minerva Cardioangiol, 2009,57 ( 6 ) :787- 812. 被引量:1

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部